Table 2 Association of complications with the age of the respondents
From: Medication utilization pattern for management of pregnancy complications: a study in Western Nepal
Complications | Age of the respondents (in years) (n,%) | Total | p value | |||||
|---|---|---|---|---|---|---|---|---|
15–19 years | 20–24 years | 25–29 years | 30–34 years | 35–39 years | 40–44 years | |||
Acid reflux disease | 1 (5) | 12 (60) | 5 (25) | 2 (10) | 0 | 0 | 20 (100) | 0.988 |
Anemia | 0 | 1 (100) | 0 | 0 | 0 | 0 | 1 (100) | |
Anxiety | 0 | 1 (50) | 0 | 1 (50) | 0 | 0 | 2 (100) | |
Asthma | 0 | 2 (66.7) | 1 (33.3) | 0 | 0 | 0 | 3 (100) | |
Constipation | 0 | 2 (50) | 2 (50) | 0 | 0 | 0 | 4 (100) | |
Depression | 0 | 0 | 0 | 1 (100) | 0 | 0 | 1 (100) | |
Diabetes mellitus | 0 | 0 | 0 | 1 (100) | 0 | 0 | 1 (100) | |
Diarrhea | 0 | 0 | 2 (66.7) | 1 (33.3) | 0 | 0 | 3 (100) | |
Dry eye | 0 | 1 (100) | 0 | 0 | 0 | 0 | 1 (100) | |
Edema | 0 | 5 (55.6) | 2 (22.2) | 1 (11.1) | 1 (11.1) | 0 | 9 (100) | |
Epilepsy | 0 | 2 (100) | 0 | 0 | 0 | 0 | 2 (100) | |
Fever/Headache | 3 (30) | 4 (40) | 3 (30) | 0 | 0 | 0 | 10 (100) | |
Hyperemesis gravidarum | 0 | 2 (40) | 3 (60) | 0 | 0 | 0 | 5 (100) | |
Hypothyroidism | 0 | 3 (60) | 1 (20) | 1 (20) | 0 | 0 | 5 (100) | |
Irritable bowel disease | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (100) | |
Itching | 1 (14.3) | 1 (14.3) | 4 (57.1) | 1 (14.3) | 0 | 0 | 7 (100) | |
Loss of appetite | 0 | 0 | 1 (50) | 1 (50) | 0 | 0 | 2 (100) | |
Loss of pregnancy | 2 (22.2) | 3 (33.3) | 2 (22.2) | 2 (22.2) | 0 | 0 | 9 (100) | |
Nausea/Vomiting | 9 (22.5) | 16 (40) | 14 (35) | 1 (2.5) | 0 | 0 | 40 (100) | |
Oligohydramnios | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (100) | |
Pain | 8 (11.9) | 31 (46.3) | 19 (28.4) | 8 (11.9) | 0 | 1 (1.5) | 67 (100) | |
Pituitary adenoma | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (100) | |
Pneumonia | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (100) | |
Polyhrdramnios | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (100) | |
Preeclampsia | 1 (16.7) | 2 (33.3) | 2 (33.3) | 1 (16.7) | 0 | 0 | 6 (100) | |
Psychosis | 1 (100) | 0 | 0 | 0 | 0 | 0 | 1 (100) | |
PV bleeding | 1 (7.1) | 9 (64.3) | 2 (14.3) | 2 (14.3) | 0 | 0 | 14 (100) | |
PV discharge | 1 (12.5) | 4 (50) | 3 (37.5) | 0 | 0 | 0 | 8 (100) | |
Thrombocytopenia | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (100) | |
Tingling sensation | 0 | 1 (50) | 0 | 1 (50) | 0 | 0 | 2 (100) | |
Total | 34 (12.4) | 121 (44) | 90 (32.7) | 27 (9.8) | 2 (0.7) | 1 (0.4) | 275 (100) | |
Tuberculosis | 0 | 0 | 1 (100) | 0 | 0 | 0 | 1 (100) | |
Upper respiratory tract infection | 5 (20.8) | 7 (29.2) | 11 (45.8) | 1 (4.2) | 0 | 0 | 24 (100) | |
Urinary tract infection | 1 (5.3) | 10 (52.6) | 6 (31.6) | 1 (5.3) | 1 (5.3) | 0 | 19 (100) | |
Weakness | 0 | 2 (100) | 0 | 0 | 0 | 0 | 2 (100) | |